Bitolterol
| Bitolterol | |
|---|---|
| Salts [] | |
|---|---|
| Bitolterol mesylate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 461.50 g/mol [1] |
| Predicted LogP | 5.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C28H31NO5 |
| IUPAC name | [4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(4-methylbenzoyl)oxyphenyl] 4-methylbenzoate |
| SMILES | CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C |
| InChI | InChI=1S/C28H31NO5/c1-18-6-10-20(11-7-18)26(31)33-24-15-14-22(23(30)17-29-28(3,4)5)16-25(24)34-27(32)21-12-8-19(2)9-13-21/h6-16,23,29-30H,17H2,1-5H3 |
| InChIKey | FZGVEKPRDOIXJY-UHFFFAOYSA-N |
| CAS number | 30392-40-6 |
| UNII | 9KY0QXD6LI |
| PubChem CID | 35330 |
| Pharmacokinetics[] | |
|---|---|
| Onset | 2–5 minutes |
| Duration of action | 6–8 hours |
Bitolterol (also known as Bitolterolum, 4-(2-(tert-butylamino)-1-hydroxyethyl)-o-phenylene di-p-toluate, 4-[2-(tert-Butylamino)-1-hydroxyethyl]-o-phenylene di-p-toluate, bitolterolo, R03ac17, Win 32784, 4-(2-(tert-butylamino)-1-hydroxyethyl)-1,2-phenylene bis(4-methylbenzoate), p-Toluic acid, 4-[2-(tert-butylamino)-1-hydroxyethyl]-o-phenylene ester ; S 1540, Bitolterol-API or 4-[2-(tert-Butylamino)-1-hydroxyethyl]-1,2-phenylene bis(4-methylbenzoate)) is a sympathomimetic substance of the catecholamine and phenylethanolamine class.
Chemistry
Salts []
Stereochemistry []
Bitolterol is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Bitolterol matches Lipinski's rule of five (violations: 1).Pharmacology
ATC Classification
- respiratory system (R)
- drugs for obstructive airway diseases (R03)
- adrenergics, inhalants (R03A)
- selective beta-2-adrenoreceptor agonists (R03AC)
- bitolterol (R03AC17)
MeSH Classification
Mechanism of action []
Bitolterol is an adrenergic beta-2 agonist. Asthma results from a narrowing of the bronchial tubes. This narrowing is caused by muscle spasm and inflammation within the bronchial tubes. Agonism of the beta-2 adrenergic receptors by bitolterol leads to a relaxation of the smooth muscles surrounding these airway tubes which then increases the diameter and ease of air flow through the tubes. [1]
Interactions []
Subjective effects []
Legal status []
- United States: Bitolterol is a Discontinued.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 35330, Bitolterol. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/35330
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bitolterol. UNII: 9KY0QXD6LI. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9KY0QXD6LI
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 06:06:15 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 06:06:11 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 06:06:11 |
| gsrs | ok | 2026-11-20 06:06:12 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0249279) | 2026-11-20 06:06:11 |
| kegg | ok | 2026-11-20 06:06:12 |
| pubchem | ok | 2026-11-20 06:06:10 |
| missing (no r/tripreports posts mention it) | 2026-11-20 06:06:11 | |
| sider | missing (not in SIDER) | 2026-11-20 06:06:11 |
| structure | ok | 2026-11-20 06:06:11 |
| wikipedia | ok | 2026-11-20 06:06:11 |